IGF1 and chronic obstructive pulmonary disease: The use of anabolic hormones, such as testosterone has been demonstrated to acutely improve muscle loss and dysfunction in patients with COPD (Casaburi et al., 2004), presumably via the IGF-1 pathway (Passey et al., 2016).